The objective of the Hebrew University of Jerusalem research is to create a deep-learning artificial infrastructure that will act like a human brain.
Researchers in Israel have conducted a study showing that vaccinating pregnant women against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early on in the third trimester may maximize transplacental antibody transfer, potentially helping to prevent severe coronavirus disease 2019 (COVID-19) during infancy.
When the world went on lockdown, nature got a reprieve, or so it seemed.
Hebrew University study shows lipid-lowering drug reduced inflammation in 48 hours and removed the need for oxygen support within 5 to 7 days for hospitalized COVID-19 patients.
Patients with psoriasis who received biologic drugs demonstrated a lower risk — that was statistically and clinically significant — for developing psoriatic arthritis, according to data published in Arthritis & Rheumatology.
Peer-reviewed research at Tel Aviv University shows previously overlooked genome alterations can be used to help identify cancer types and predict patients’ chances of survival
Integrated DNA Technologies describes methods that can be used to quantify and characterize off-target editing in gene editing experiments
The treatment under development works against a novel target: succinate, a pro-inflammatory molecule secreted by gut bacteria.
Israeli scientists say they have identified three existing drugs that have good prospects as COVID-19 treatments, reporting that they illustrated a high ability to fight the virus in lab tests.
Since the start of the COVID-19 pandemic, the scientific community has been bewildered by a mystery: why does the elderly population appear to be more vulnerable to COVID-19, and why are vaccines less effective in protecting them?